JG
Jeff Garro Stephens & Co. Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Privia Health
PRVA
$2.78B
| $22.67 | $32 |
41%
upside
| Overweight |
4 Sep ‘25
8 days ago |
|
2
Phreesia
PHR
$1.48B
| $24.77 | $32 |
29%
upside
| Overweight |
3 Sep ‘25
9 days ago |
|
3
Simulations Plus
SLP
$286M
| $14.21 | $20 |
41%
upside
| Overweight |
15 Jul ‘25
1 month ago |
|
4
TruBridge
TBRG
$307M
| $20.46 | $28 |
37%
upside
| Equal-Weight |
10 Apr ‘25
5 months ago |
|
5
Veeva Systems
VEEV
$45.6B
| $277.94 | $280 |
1%
upside
| Overweight |
6 Mar ‘25
6 months ago |
|
6
Health Catalyst
HCAT
$223M
| $3.17 | $5 |
58%
upside
| Equal-Weight |
6 Mar ‘25
6 months ago |
|
7
Certara
CERT
$1.8B
| $11.19 | $17 |
52%
upside
| Overweight |
27 Feb ‘25
6 months ago |
|
8
Evolent Health
EVH
$1.06B
| $9.18 | $12 |
31%
upside
| Equal-Weight |
21 Jan ‘25
7 months ago |
|
9
Definitive Healthcare
DH
$418M
| $4.02 | $5 |
24%
upside
| Equal-Weight |
20 Dec ‘24
8 months ago |
|
10
Doximity
DOCS
$13.3B
| $71.25 | $55 |
23%
downside
| Equal-Weight |
20 Dec ‘24
8 months ago |
|
11
OptimizeRx
OPRX
$342M
| $18.41 | $5.50 |
70%
downside
| Equal-Weight |
20 Dec ‘24
8 months ago |
|
12
IQVIA
IQV
$32B
| $188.47 | $250 |
33%
upside
| Overweight |
20 Dec ‘24
8 months ago |
|
13
Hallador Energy
HNRG
$749M
| $17.42 | $17 |
2%
downside
| Buy |
9 Dec ‘24
9 months ago |
|
14
Teladoc Health
TDOC
$1.35B
| $7.65 | $28 |
266%
upside
| Equal-Weight |
26 Jul ‘23
2 years ago |
|
15
NeueHealth
NEUE
$60.9M
| $6.75 | $240 |
3,456%
upside
| Overweight |
11 Aug ‘22
3 years ago |
|
|
16
Certara
CERT
$1.8B
| $11.19 | $25 |
123%
upside
| Overweight |
10 Aug ‘22
3 years ago |
|
|
17
OptimizeRx
OPRX
$342M
| $18.41 | $16 |
13%
downside
| Neutral |
10 Aug ‘22
3 years ago |
|
18
Alignment Healthcare
ALHC
$3.2B
| $16.16 | $20 |
24%
upside
| Overweight |
5 Aug ‘22
3 years ago |
|
19
InnovAge Holding
INNV
$597M
| $4.41 | $3.90 |
12%
downside
| Underweight |
11 May ‘22
3 years ago |
|
20
SelectQuote
SLQT
$363M
| $2.10 | $3 |
43%
upside
| Neutral |
6 May ‘22
3 years ago |
|
|
21
IQVIA
IQV
$32B
| $188.47 | $255 |
35%
upside
| Overweight |
29 Apr ‘22
3 years ago |
|